A review of the advancements in probiotic delivery: Conventional vs. Non-conventional formulations for intestinal flora supplementation

AAPS PharmSciTech

Volumn 15, Issue 1, 2014, Pages 29-43

  Govender, Mershen ^a   Choonara, Yahya E ^a   Kumar, Pradeep ^a   Du Toit, Lisa C ^a   Van Vuuren, Sandy ^a   Pillay, Viness ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

conventional and non conventional formulations; drug delivery systems design; intestinal flora; nutraceutical products; probiotics

Indexed keywords

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; INTESTINES; PROBIOTICS;

EID: 84893699458     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-0027-1     Document Type: Review

References (115)

1. Fuller R. Probiotics in human medicine. Gut. 1991;32(4):439-42. doi: 10.1136/gut.32.4.439.
2. Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 2000;84(3):197-215. doi: 10.1016/S0168-1656(00)00375-8.
3. FAO-WHO. Food and Health Agricultural Organization of the United Nations and World Health Organization. Guidelines for the evaluation of probiotics in food. Working Group Rep, Food and Health Agricultural Organization of the United Nations and World Health Organization, Washington, DC. 2002.
4. Collado MC, Meriluoto J, Salminen S. In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food Res Intl. 2007;40(5):629-36. doi: 10.1016/j.foodres.2006.11.007.
5. Bosch M, Nart J, Audivert S, Bonachera MA, Alemany AS, Fuentes MC, et al. Isolation and characterization of probiotic strains for improving oral health. Arch Oral Biol. 2012;57(5):539-49. doi: 10.1016/j.archoralbio.2011.10.006.
6. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc. 2001;101(2):229-38. doi: 10.1016/S0002-8223(01)00060-8. 241.
7. Del Piano M, Morellic L, Strozzi GP, Allesina S, Barba M, Deidda F, et al. Probiotics: from research to consumer. Digest Liver Dis. 2006;38 Suppl 2:248-55. doi: 10.1016/S1590-8658(07)60004-8.
8. Lourens-Hattingh A, Viljoen BC. Yogurt as probiotic carrier food. Int Diary J. 2001;11(1-2):1-17. doi: 10.1016/S0958-6946(01)00036-X.
9. Stevenson C, Blaauw R. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. S Afr J Clin Nutr. 2011;24(2):63-73.
10. Todd J. Dairy products in infant nutrition-latest developments. Aust J Dairy Technol. 2003;58(2):55-7.
11. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123(2):335-41. doi: 10.1016/j.jaci.2008.11.019.
12. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 2010;29(6):701-25. doi: 10.1016/j.clnu.2010.05. 004.
13. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huisin'tVeld JHJ. Overview of gut flora and probiotics. Int J Food Microbiol. 1998;41(2):85-101.
14. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immun. 2001;8(2):293-6. doi: 10.1128/CDLI.8.2.293-296.2001.
15. Janer C, Pelaez C, Requena T. Caseinomacropeptide and whey protein concentrate enhance Bifidobacterium lactis growth in milk. Food Chem. 2004;86(2):263-7. doi: 10.1016/j.foodchem.2003.09.034.
16. Penner R, Fedorak RN, Madsen KL. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol. 2005;5(6):596-603. doi: 10.1016/j.coph.2005.06.009.
17. Sunada Y, Nakamura S, Kamei C. Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol. 2008;8(13-14):1761-6. doi: 10.1016/j.intimp.2008.08.011.
18. Mitsuoka T. Recent trends in research on intestinal flora. Bifidobacteria Microflora. 1982;1:3-24.
19. Hove H, Norgaard H, Mortensen PB. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr. 1999;53(5):339-50. doi: 10.1038/sj.ejcn.1600773.
20. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: metaanalysis. BMJ. 2002;324:1361. doi: 10.1136/bmj.324.7350.1361.
21. McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 2008;364(2):213-26. doi: 10.1016/j.ijpharm.2008.05.012.
22. Yamada T, Alpers D, Kalloo AN, Kaplowitz N, Owyang C, Powell DW. Principles of clinical gastroenterology. West Sussex: Wiley; 2008.
23. Reiff C, Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Food Microbiol. 2010;300(1):25-33. doi: 10.1016/j.ijmm.2009.08. 004.
24. Beachey EH. Bacterial adherence: adhesion-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis. 1981;143(3):325-45.
25. Vasiljevic T, Shah NP. Probiotics - from Metchnikoff to bioactives. Int Diary J. 2008;18(7):714-28. doi: 10.1016/j.idairyj.2008.03.004.
26. Rivera-Espinoza Y, Gallardo-Navarro Y. Non-dairy probiotic products. Food Microbiol. 2010;27(1):1-11. doi: 10.1016/j.fm.2008.06.008.
27. Verna EC, Lucak S. Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol. 2010;3(5):307-19. doi: 10.1177/1756283X10373814.
28. Alander M, Matto J, Kneifel W, Johansson M, Kogler B, Crittenden R, et al. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int Diary J. 2001;11(10):817-25. doi: 10.1016/S0958-6946(01)00100-5.
29. Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E. The prokaryotes: a handbook on the biology of bacteria, bacteria: firmicutes, cyanobacteria. 3rd ed. New York: Springer Science + Business Media; 2006.
30. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008;14(3):166-71. doi: 10.1016/j.anaerobe.2008.02.001.
31. Quigley EMM. Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res. 2010;61(3):213-8. doi: 10.1016/j.phrs.2010.01.004.
32. Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV. Microencapsulation of probiotics for gastrointestinal delivery. J Control Release. 2012;162(1):56-67. doi: 10.1016/j.jconrel.2012.06.003.
33. Maragkoudakis PA, Zoumpopoulou G, Miaris C, Kalantzopoulos G, Pot B, Tsakalidou E. Probiotic potential of Lactobacillus strains isolated from dairy products. Int Diary J. 2006;16(3):189-99. doi: 10.1016/j.idairyj.2005.02.009.
34. Rabiu BA, Gibson GR. Carbohydrates: a limit on bacterial diversity within the colon. Biol Rev. 2002;77(3):443-53. doi: 10.1017/S1464793102005961.
35. Stanton C, Lynch PB, Collins JK, Fitzgerald G, Ross RP. Probiotic cheese. Int Diary J. 1998;8(5):491-6. doi: 10.1016/S0958-6946(98)00080-6.
36. Joosten H, Bidlas E, Garofalo N. Salmonella detection in probiotic products. Int J Food Microbiol. 2006;110(1):104-7. doi: 10.1016/j.ijfoodmicro. 2006.01.036.
37. Khan MI, Arshad MS, Anjum FM, Sameen A, ur-Rehman A, Gill WT. Meat as a functional food with special reference to probiotic sausages. Food Res Int. 2011;44(10):3125-33. doi: 10.1016/j.foodres.2011.07.033.
38. Cousin FJ, Louesdon S, Maillard MB, Parayre S, Falentin H, Deutsch SM, et al. The first dairy product exclusively fermented by Propionibacterium freudenreichii: a new vector to study probiotic potentialities in vivo. Food Microbiol. 2012;32(1):135-46. doi: 10.1016/j.fm.2012.05.003.
39. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics - approaching a definition. Am J Clin Nutr. 2001;77 Suppl 2:361S-4S.
40. Lund B, Adamsson I, Edlund C. Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin. Int J Food Microbiol. 2002;77(1-2):109-15. doi: 10.1016/S0168-1605(02)00047-8.
41. Mattila-Sandholm T, Myllärinen P, Crittenden R, Mogensen G, Fondén R, Saarela M. Technological challenges for future probiotic foods. Int Diary J. 2002;12(2-3):173-82. doi: 10.1016/S0958-6946(01)00099-1.
42. Ding WK, Shah NP. Acid, bile and heat tolerance of free and microencapsulated probiotic bacteria. J Food Sci. 2007;72(9):446-50. doi: 10.1111/j.1750-3841.2007.00565.x.
43. Siepmann F, Wahle C, Leclercq B, Carlin B, Siepmann J. pH-sensitive film coatings: towards a better understanding and facilitated optimization. Eur J Pharm Biopharm. 2008;68(1):2-10. doi: 10.1016/j.ejpb.2007.03.025.
44. Hou RCW, Lin MY, Wang MMC, Tzen JTC. Increase of viability of entrapped cells of Lactobacillus delbrueckii ssp. bulgaricus in artificial sesame oil emulsions. J Dairy Sci. 2003;86(2):424-8. doi: 10.3168/jds.S0022-0302(03)73620- 0.
45. Doleyres Y, Lacroix C. Technologies with free and immobilised cells for probiotic bifidobacteria production and protection. Int Diary J. 2005;15(10):973-88. doi: 10.1016/j.idairyj.2004.11.014.
46. Oliveira RPS, Florence ACR, Silva RC, Perego P, Converti A, Gioielli LA, et al. Effect of different prebiotics on the fermentation kinetics, probiotic survival and fatty acids profiles in nonfat symbiotic fermented milk. Int J Food Microbiol. 2009;128(3):467-72. doi: 10.1016/j.ijfoodmicro.2008.10.012.
47. Krasaekoopt W, Bhandari B, Deeth H. The influence of coating materials on some properties of alginate beads and survivability of microencapsulated probiotic bacteria. Int Diary J. 2004;14(8):737-43. doi: 10.1016/j.idairyj.2004. 01.004.
48. Jensen H, Grimmer S, Naterstad K, Axelsson L. In vitro testing of commercial and potential probiotic lactic acid bacteria. Int J Food Microbiol. 2012;153(1-2):216-22. doi: 10.1016/j.ijfoodmicro.2011.11.020.
49. Bhardwaj A, Gupta H, Kapila S, Kaur G, Vij S, Malik RK. Safety assessment and evaluation of probiotic potential of bacteriocinogenic Enterococcus faecium KH 24 strain under in vitro and in vivo conditions. Int J Food Microbiol. 2010;141(3):156-64. doi: 10.1016/j.ijfoodmicro.2010.05.001.
50. Copeland DR, McVay MR, Dassinger MS, Jackson RJ, Smith SD. Probiotic fortified diet reduces bacterial colonization and translocation in a long-term neonatal rabbit model. J Pediatr Surg. 2009;44(6):1061-4. doi: 10.1016/j.jpedsurg.2009.02.014.
51. Buddenborg C, Daudel D, Liebrecht S, Greune L, Humberg V, Schmidt MA. Development of a tripartite vector system for live oral immunization using a Gram-negative probiotic carrier. Int J Med Microbiol. 2008;298(1-2):105-14. doi: 10.1016/j.ijmm.2007.08.008.
52. Panigrahi A, Kiron V, Satoh S, Hirono I, Kobayashi T, Sugita H, et al. Immune modulation and expression of cytokine genes in rainbow trout Oncorhynchus mykiss upon probiotic feeding. Dev Comp Immunol. 2007;31(4):372-82. doi: 10.1016/j.dci.2006.07.004.
53. Tseng DY, Ho PL, Huang SY, Cheng SC, Shiu YL, Chiu CS, et al. Enhancement of immunity and disease resistance in the white shrimp, Litopenaeus vannamei, by the probiotic, Bacillus subtilis E20. Fish Shellfish Immunol. 2009;26(2):339-44. doi: 10.1016/j.fsi.2008.12.003.
54. Cross ML. Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health. Clin Appl Immunol Rev. 2002;3(3):115-25. doi: 10.1016/S1529-1049(02)00057-0.
55. Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol. 2007;297(3):151-62. doi: 10.1016/j.ijmm.2007.01.008.
56. Makinen K, Berger B, Bel-Rhlid R, Ananta E. Science and technology for the mastership of probiotic applications in food products. J Biotechnol. 2012;162(4):356-65. doi: 10.1016/j.jbiotec.2012.07.006.
57. Grzeskowiak L, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe. 2012;18(1):7-13. doi: 10.1016/j.anaerobe.2011.09.006.
58. Guerra NP, Bernardez PF, Mendez J, Cachaldora P, Castro LP. Production of four potentially probiotic lactic acid bacteria and their evaluation as feed additives for weaned piglets. Anim Feed Sci Tech. 2007;134(1):89-107. doi: 10.1016/j.anifeedsci.2006.05.010.
59. Madden JAJ, Plummer SF, Tang J, Garaiova I, Plummer NT, Herbison M, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005;5(6):1091-7. doi: 10.1016/j.intimp.2005.02.006.
60. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Ch. 1987;31(8):1231-3. doi: 10.1128/AAC.31.8.1231.
61. Santiago GL, Verstraelen H, Poelvoorde N, De Corte S, Claeys G, Trog M, et al. A pilot study evaluating the safety of vaginal administration of a multi-particulate pellet formulation. Eur J Pharm Biopharm. 2009;73(3):399-403. doi: 10.1016/j.ejpb.2009.08.009.
62. Douglas LC, Sanders ME. Probiotics and prebiotics in dietetics practice. J Am Diet Assoc. 2008;108(3):510-21. doi: 10.1016/j.jada.2007.12.009.
63. Mombelli B, Gismondo MR. The use of probiotics in medical practice. Int J Antimicrob Ag. 2000;16(4):531-6. doi: 10.1016/S0924-8579(00)00322-8.
64. Scheinbach S. Probiotics: functionality and commercial status. Biotechnol Adv. 1998;16(3):581-608. doi: 10.1016/S0734-9750(98)00002-0.
65. Dash SK, Spreen AN, Ley BM. Health benefits of probiotics. Temecula: BL Publications; 1999.
66. Roueche E, Serris E, Thomas G, Perier-Camby L. Influence of temperature on the compaction of an organic powder and the mechanical strength of tablets. Powder Technol. 2006;162(2):138-44. doi: 10.1016/j.powtec.2005.12.005.
67. Ong L, Henriksson A, Shah NP. Development of probiotic Cheddar cheese containing Lactobacillus acidophilus, Lb. casei, Lb. paracasei and Bifidobacterium spp. and the influence of these bacteria on proteolytic patterns and production of organic acid. Int Diary J. 2006;16(5):446-56. doi: 10.1016/j.idairyj.2005.05.008.
68. Medici M, Vinderola CG, Perdigon G. Gut mucosal immunomodulation by probiotic fresh cheese. Int Diary J. 2004;14(7):611-8. doi: 10.1016/j.idairyj. 2003.10.011.
69. Minelli EB, Benini A, Marzotto M, Sbarbati A, Ruzzenente O, Ferrario R, et al. Assessment of novel probiotic Lactobacillus casei strains for the production of functional dairy foods. Int Diary J. 2004;14(8):723-36. doi: 10.1016/j.idairyj.2004.01.007.
70. Phillips M, Kailasapathy K, Tran L. Viability of commercial probiotic cultures (L. acidophilus, Bifidobacterium sp. L. casei, L. paracasei and L. rhamnosus) in cheddar cheese. Int J Food Microbiol. 2006;108(2):276-80.
71. Bergamini CV, Hynes ER, Quiberoni A, Suarez VB, Zalazar CA. Probiotic bacteria as adjunct starters: influence of the addition methodology on their survival in a semi-hard Argentinean cheese. Food Res Int. 2005;38(5):597-604. doi: 10.1016/j.foodres.2004.11.013.
72. Ong L, Shah NP. Probiotic cheddar cheese: influence of ripening temperatures on survival of probiotic microorganisms, cheese composition and organic acid profiles. LWT- Food Sci Technol. 2009;42(7):1260-8. doi: 10.1016/j.lwt.2009.01.011.
73. Hemsworth J, Hekmat S, Reid G. The development of micronutrient supplemented probiotic yogurt for people living with HIV: laboratory testing and sensory evaluation. Innov Food Sci Emerg. 2011;12(1):79-84. doi: 10.1016/j.ifset.2010.11.004.
74. Marafon AP, Sumi A, Alcantara MR, Tamime AY, de Oliveira MN. Optimization of the rheological properties of probiotic yoghurts supplemented with milk proteins. LWT- Food Sci Technol. 2011;44(2):511-9. doi: 10.1016/j.lwt.2010.09. 005.
75. Possemiers S, Marzorati M, Verstraete W, Van de Wiele T. Bacteria and chocolate: a successful combination for probiotic delivery. Int J Food Microbiol. 2010;141(1-2):97-103. doi: 10.1016/j.ijfoodmicro.2010.03.008.
76. Aragon-Alegroa LC, Alegro JHA, Cardarelli HR, Chiu MC, Saad SMI. Potentially probiotic and synbiotic chocolate mousse. LWT. 2007;40(4):669-75. doi: 10.1016/j.lwt.2006.02.020.
77. Senaka Ranadheera C, Evans CA, Adams MC, Baines SK. In vitro analysis of gastrointestinal tolerance and intestinal cell adhesion of probiotics in goat's milk ice cream and yogurt. Food Res Int. 2012;49(2):619-25. doi: 10.1016/j.foodres.2012.09.007.
78. Khalf M, Dabour N, Kheadr E, Fliss I. Viability of probiotic bacteria in maple sap products under storage and gastrointestinal conditions. Bioresource Technol. 2010;101(20):7966-72. doi: 10.1016/j.biortech.2010.05.053.
79. Kos B, Suskovic J, Beganovic J, Gjuracic K, Frece J, Iannaccone C, et al. Characterization of the three selected probiotic strains for the application in food industry. World J Microbiol Biotechnol. 2008;24(5):699-707. doi: 10.1007/s11274-007-9528-y.
80. Bolla PA, de los Angeles Serradell M, de Urraza PJ, De Antoni GL. Effect of freeze-drying on viability and in vitro probiotic properties of a mixture of lactic acid bacteria and yeasts isolated from kefir. J Dairy Res. 2011;78(1):15-22. doi: 10.1017/S0022029910000610.
81. Zarate G, Nader-Macias ME. Viability and biological properties of probiotic vaginal lactobacilli after lyophilization and refrigerated storage into gelatin capsules. Process Biochem. 2006;41(8):1779-85. doi: 10.1016/j.procbio.2006.03.024.
82. Vincenzetti S, Savini M, Cecchini C, Micozzi D, Carpi F, Vita A, Polidori P. Effects of Lyophilization and Use of Probiotics on Donkey's Milk Nutritional Characteristics. Int J Food Eng. 2011;7(5), Article 8. doi: 10.2202/1556-3758.2032.
83. Savini M, Cecchini C, Verdenelli MC, Silvi S, Orpianesi C, Cresci A. Pilot-scale production and viability analysis of freeze-dried probiotic bacteria using different protective agents. Nutrients. 2010;2(3):330-9. doi: 10.3390/nu2030330.
84. Heidebach T, Forst P, Kulozik U. Influence of casein-based microencapsulation on freeze-drying and storage of probiotic cells. J Food Eng. 2010;98(3):309-16. doi: 10.1016/j.jfoodeng.2010.01.003.
85. Weinbreck F, Bodnar I, Marco ML. Can encapsulation lengthen the shelf-life of probiotic bacteria in dry products? Int J Food Microbiol. 2010;136(3):364-7. doi: 10.1016/j.ijfoodmicro.2009.11.004.
86. Vesterlund S, Salminen K, Salminen S. Water activity in dry foods containing live probiotic bacteria should be carefully considered: a case study with Lactobacillus rhamnosus GG in flaxseed. Int J Food Microbiol. 2012;157(2):319-21. doi: 10.1016/j.ijfoodmicro.2012.05.016.
87. Zayed G, Roos YH. Influence of trehalose and moisture content on survival of Lactobacillus salivarius subjected to freeze-drying and storage. Process Biochem. 2004;39(9):1081-6. doi: 10.1016/S0032-9592(03)00222-X.
88. Vitali B, Ndagijimana M, Maccaferri S, Biagi E, Guerzoni ME, Brigidi P. An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota. Anaerobe. 2012;18(4):386-91. doi: 10.1016/j.anaerobe.2012.04.014.
89. Bauer SAW, Schneider S, Behr J, Kulozik U, Foerst P. Combined influence of fermentation and drying conditions on survival and metabolic activity of starter and probiotic cultures after low-temperature vacuum drying. J Biotechnol. 2012;159(4):351-7. doi: 10.1016/j.jbiotec.2011.06.010.
90. Juarez Tomas MS, Ocana VS, Nader-Macias ME. Viability of vaginal probiotic lactobacilli during refrigerated and frozen storage. Anaerobe. 2004;10(1):1-5. doi: 10.1016/j.anaerobe.2004.01.002.
91. Dave RI, Shah NP. Viability of yoghurt and probiotic bacteria in yoghurts made from commercial starter cultures. Int Diary J. 1997;7(1):31-41. doi: 10.1016/S0958-6946(96)00046-5.
92. Klayraung S, Viernstein H, Okonogi S. Development of tablets containing probiotics: effects of formulation and processing parameters on bacterial viability. Int J Pharm. 2009;370(1-2):54-60. doi: 10.1016/j.ijpharm.2008.11.004.
93. Calinescu C, Mulhbacher J, Nadeau E, Fairbrother JM, Mateescu MA. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulation. Eur J Pharm Biopharm. 2005;60(1):53-60. doi: 10.1016/j.ejpb.2004.12.006.
94. Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm. 2002;235(1-2):1-15. doi: 10.1016/S0378-5173(02)00004-2.
95. Calinescu C, Nadeau E, Mulhbacher J, Fairbrother JM, Mateescu MA. Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation. Int J Pharm. 2007;343(1-2):18-25. doi: 10.1016/j.ijpharm.2007.04. 017.
96. Chan ES, Zhang Z. Bioencapsulation by compression coating of probiotic bacteria for their protection in an acidic medium. Process Biochem. 2005;40(10):3346-51. doi: 10.1016/j.procbio.2005.03.001.
97. Poulin JF, Caillard R, Subirade M. β-Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteria. Int J Pharm. 2011;405(1-2):47-54. doi: 10.1016/j.ijpharm.2010.11.041.
98. Doherty SB, Gee VL, Ross RP, Stanton C, Fitzgerald GF, Brodkorb A. Development and characterisation of whey protein micro-beads as potential matrices for probiotic protection. Food Hydrocolloid. 2011;25(6):1604-17. doi: 10.1016/j.foodhyd.2010.12.012.
99. Heidebach T, Forst P, Kulozik U. Microencapsulation of probiotic cells by means of rennet-gelation of milk proteins. Food Hydrocolloid. 2009;23(7):1670-7. doi: 10.1016/j.foodhyd.2009.01.006.
100. Kaushal G, Shao J. Oral delivery of β-lactamase by Lactococcus lactis subsp. lactis transformed with Plasmid ss80. Int J Pharm. 2006;312(1-2):90-5.
101. Brachkova MI, Duarte MA, Pinto JF. Preservation of viability and antibacterial activity of Lactobacillus spp. in calcium alginate beads. Eur J Pharm Sci. 2010;41(5):589-96. doi: 10.1016/j.ejps.2010.08.008.
102. Chandramouli V, Kailasapathy K, Peiris P, Jones M. An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J Microbiol Methods. 2004;56(1):27-35. doi: 10.1016/j.mimet.2003.09.002.
103. Albertini B, Vitali B, Passerini N, Cruciani F, Di Sabatino M, Rodriguez L, et al. Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis. Eur J Pharm Sci. 2010;40(4):359-66. doi: 10.1016/j.ejps.2010.04.011.
104. TM as a possible probiotic for the urogenital tract. Int Diary J. 2000;10(5-6):415-9. doi: 10.1016/S0958-6946(00)00059-5.
105. Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol. 2010;203(2):120.e1-6. doi: 10.1016/j.ajog.2010.05. 023.
106. Kailasapathy K. Survival of free and encapsulated probiotic bacteria and their effect on the sensory properties of yoghurt. LWT. 2006;39(10):1221-7. doi: 10.1016/j.lwt.2005.07.013.
107. Saxelin M, Lassig A, Karjalainen H, Tynkkynen S, Surakka A, Vapaatalo H, et al. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int J Food Microbiol. 2010;144(2):293-300. doi: 10.1016/j.ijfoodmicro.2010.10.009.
108. Sultana K, Godward G, Reynolds N, Arumugaswamy R, Peiris P, Kailasapathy K. Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. Int J Food Microbiol. 2000;62(1-2):47-55. doi: 10.1016/S0168-1605(00)00380-9.
109. Jankovic I, Sybesma W, Phothirath P, Ananta E, Mercenier A. Application of probiotics in food products- challenges and new approaches. Curr Opin Biotech. 2010;21(2):175-81. doi: 10.1016/j.copbio.2010.03.009.
110. O'Brien J, Crittenden R, Ouwehand AC, Salminen S. Safety evaluation of probiotics. Trends Food Sci Tech. 1999;10(12):418-24. doi: 10.1016/S0924- 2244(00)00037-6.
111. Zhou JS, Gill HS. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Int J Food Microbiol. 2005;103(1):97-104. doi: 10.1016/j.ijfoodmicro.2004.11.031.
112. Molly K, Vande Woestyne M, Verstraete W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biot. 1993;39(2):254-8. doi: 10.1007/BF00228615.
113. Alander M, De Smet I, Nollet L, Verstraete W, von Wright A, Mattila-Sandholm T. The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). Int J Food Microbiol. 1999;46(1):71-9. doi: 10.1016/S0168-1605(98)00182-2.
114. De Boever P, Deplancke B, Verstraete W. Fermentation by Gut Microbiota Cultured in a Simulator of the Human Intestinal Microbial Ecosystem Is Improved by Supplementing a Soygerm Powder. J Nutr. 2000;130(10):2599-606.
115. Mare L, Wolfaardt GM, Dicks LMT. Adhesion of Lactobacillus plantarum 423 and Lactobacillus salivarius 241 to the intestinal tract of piglets, as recorded with fluorescent in situ hybridization (FISH), and production of plantaricin 423 by cells colonized to the ileum. J Appl Microbiol. 2005;100(4):838-45. doi: 10.1111/j.1365-2672.2006.02835.x.